carbidopa has been researched along with Multiple System Atrophy in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Blaise, AS; Carrière, N; Cuvelier, E; Defebvre, L; Devos, D; Moreau, F; Mutez, E | 1 |
| Goldstein, DS; Holmes, C; Kopin, IJ; Pechnik, S; Sewell, L | 1 |
| Ahlskog, JE; Josephs, KA; Kumar, N; Matsumoto, JY; McKeon, A; Savica, R | 1 |
| Apetauerova, D; Norregaard, T; Ryan, P; Tarsy, D | 1 |
| Kaufmann, H | 1 |
| Kimber, J; Mathias, CJ; Watson, L | 1 |
1 review(s) available for carbidopa and Multiple System Atrophy
| Article | Year |
|---|---|
L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience.
Topics: Autonomic Nervous System Diseases; Blood Pressure; Carbidopa; Central Nervous System Diseases; Controlled Clinical Trials as Topic; Droxidopa; Humans; Hypotension, Orthostatic; Levodopa; Multiple System Atrophy; Norepinephrine; United States | 2008 |
1 trial(s) available for carbidopa and Multiple System Atrophy
| Article | Year |
|---|---|
Effects of carbidopa and entacapone on the metabolic fate of the norepinephrine prodrug L-DOPS.
Topics: Aged; Antiparkinson Agents; Blood Pressure; Carbidopa; Catechols; Double-Blind Method; Droxidopa; Drug Interactions; Female; Humans; Male; Middle Aged; Multiple System Atrophy; Nitriles; Norepinephrine; Parkinson Disease; Prodrugs; Pure Autonomic Failure; Vasoconstriction | 2011 |
4 other study(ies) available for carbidopa and Multiple System Atrophy
| Article | Year |
|---|---|
Use of levodopa-carbidopa intestinal gel to treat patients with multiple system atrophy.
Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Gels; Humans; Levodopa; Multiple System Atrophy; Parkinson Disease; Retrospective Studies | 2022 |
Parkinsonism and dropped head: dystonia, myopathy or both?
Topics: Aged; Carbidopa; Drug Combinations; Dystonic Disorders; Electromyography; Female; Head Movements; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Muscular Diseases; Parkinsonian Disorders; Retrospective Studies | 2012 |
Adverse effects of subthalamic nucleus DBS in a patient with multiple system atrophy.
Topics: Antiparkinson Agents; Atrophy; Carbidopa; Combined Modality Therapy; Contraindications; Deglutition Disorders; Diagnosis, Differential; Dysarthria; Electric Stimulation Therapy; Electrodes, Implanted; Female; Humans; Levodopa; Magnetic Resonance Imaging; Microelectrodes; Middle Aged; Multiple System Atrophy; Parkinson Disease; Pons; Putamen; Subthalamic Nucleus | 2003 |
Neuroendocrine responses to levodopa in multiple system atrophy (MSA).
Topics: Adult; Aged; Antiparkinson Agents; Blood Glucose; Carbidopa; Dopamine; Drug Combinations; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Insulin-Like Growth Factor I; Levodopa; Male; Middle Aged; Multiple System Atrophy; Reference Values; Thyrotropin | 1999 |